MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Research
Written by / Agency / Source: Tractebel
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Innovative MYRRHA Research Reactor Starting to Take Shape - The world’s first prototype of a high-power research reactor driven by a particle accelerator is taking shape with the contribution of Tractebel nuclear and urban experts - MYRRHA.be / Tractebel-Engie.com
Innovative MYRRHA Research Reactor Starting to Take Shape

 

NewswireToday - /newswire/ - Mol, Belgium, 2019/11/06 - The world’s first prototype of a high-power research reactor driven by a particle accelerator is taking shape with the contribution of Tractebel nuclear and urban experts - MYRRHA.be / Tractebel-Engie.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A First agreement worth 7,6 million euros for the design of buildings and utilities was signed on November 5.

On November 5, the first agreement for the implementation of the innovative MYRRHA research reactor was signed between the Belgian Nuclear Research Centre (SCK•CEN) (sckcen.be), Tractebel and Empresarios Agrupados Internacional. MYRRHA (myrrha.be), which stands for Multi-purpose Hybrid Research Reactor for High-tech Applications, is the world’s first prototype of a high-power research reactor driven by a particle accelerator. Its ambition is to offer a technological solution to reduce nuclear waste and produce medical radioisotopes for innovative cancer treatments.

The 7,6 million euros agreement signed on November 5 is for the design of buildings and utilities (cooling, water and electricity) of MINERVA, the particle accelerator up to 100 MeV energy, and the related Proton Target Facility. The main building is a tunnel that will be housing the first part of MINERVA and will be 150 meters long, 7.5 meters wide with a height of 3.5 meters. “We are delighted to announce that we have signed an agreement with Tractebel and Empresarios Agrupados. It is the first major contribution of MYRRHA to the Belgian economy,” said Hamid Aït Abderrahim, Deputy Director General at SCK•CEN and MYRRHA Director.

The mission of Tractebel (tractebel-engie.com) and its partner Empresarios Agrupados (empresariosagrupados.es) will be divided into three main phases: design of the Balance of Plant (BOP) of MINERVA, preparation and follow-up of the procurement with the contractors, and assistance during the construction phase. “It is an honour for Tractebel to team up with Empresarios Agrupados in this critical design engineering mission and we thank SCK•CEN for their trust. MYRRHA is fully in line with Tractebel purpose of engineering a zero-carbon future and our strategy focused on the diversification of our nuclear expertise towards advanced technologies and medical applications,” said Denis Dumont, General Manager Business Line Nuclear at Tractebel.

The Belgian government has invested 558 million euros on MYRRHA. The implementation of the particle accelerator MINERVA, which is expected to be commissioned in 2026, is the first out of three phases of the overall MYRRHA project.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Tractebel

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Innovative MYRRHA Research Reactor Starting to Take Shape

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Press Office - Tractebel-Engie.com 
press[.]tractebel-engie.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Tractebel securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Tractebel / Company Profile


Read Research Most Recent Related Newswires:

Increasing Demand for Real Time Access Boosts the Global Image Recognition Market At 21.00% CAGR According to Inkwood Research
BASF and BNP Brinkmann Acting as Project Partners to Support Current DLR Research on the Future of Mobility
BASF and CTIBiotech to Develop First 3D Bioprinted Human Reconstructed Skin Including Immune Macrophages
Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies, LLC
Rohde & Schwarz and Martin Luther University Halle-Wittenberg Establish Research Partnership
Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications
Biomedical Software Startup BostonGene Secures M in Series A Financing from NEC
Imec, UZ Leuven, KU Leuven, The Ghent University, Agilent, Western Digital and BlueBee Develop Unique Hybrid Cloud Platform
Digital Revolution - Naval Group, B<>com’s New Industrial Investor
Bruker and the Translational Metabolic Lab At Radboud University Announce the Establishment of A Joint Center of Excellence for Translational Omics
Rohde & Schwarz and Helmut Schmidt University Hamburg Conduct Joint Research
Imec Researcher Receives ERC Advanced Grant to Develop Ultra-bright Thin-film Light Sources and Lasers
DSM Sets Science-based Reduction Targets for Emissions
Novel Nanomaterial Promises Improvements in Batteries and Many More Sustainable Applications
OnePlanet, a New Dutch Innovation Center for Food, Health and Agricultural Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2019 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)